Skip to main content
Premium Trial:

Request an Annual Quote

China Medical Technologies Spends $345M for Rights to HPV Testing Platform

NEW YORK (GenomeWeb News) – China Medical Technologies said yesterday that it had entered into a definitive agreement to acquire a molecular diagnostic test for human papillomavirus and an analysis platform from Molecular Diagnostic Technologies for $345 million.
The Beijing-based firm said that it will acquire the HPV-DNA Biosensor Chip and a surface plasmon resonance-based system for detecting the virus.
According to CMT, the label-free DNA chip can identify each of the 24 distinctive common HPV genotypes, including 16 high-risk genotypes and 8 low-risk genotypes. The firm said that it can also rapidly identify mixed HPV infection and can be used to guide individual therapy and vaccination.
CMT expects to complete the asset acquisition in either this coming December or January. It said that it expects to use existing cash holdings to pay for the technology.
The company plans to bundle sales of the HPV chip with its FISH probes to detect both HPV infection and human telomerase gene amplification “to achieve early diagnosis of cervical cancer and to provide treatment guidance,” Xiaodong Wu, chairman and CEO of CMT, said in a statement.
He estimated that the market potential for the HPV chip in China is around $700 million. The firm expects the chip to generate revenues of roughly $23.6 million to $26.5 million in 2009.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.